NEW YORK, July 17, 2019 /PRNewswire/ -- Phreesia, Inc.
("Phreesia"), a leading patient intake management platform, today
announced the pricing of its initial public offering of 9,288,194
shares of common stock at a public offering price of $18.00 per share, before underwriting discounts,
consisting of 7,812,500 shares to be issued and sold by Phreesia
(the "Primary Shares") and 1,475,694 shares to be sold by certain
of Phreesia's existing stockholders (the "Secondary Shares" and,
together with the Primary Shares, the "Shares"). The Shares are
scheduled to begin trading on the New York Stock Exchange on
July 18, 2019 under the ticker symbol
"PHR."
In addition, the selling stockholders have granted the
underwriters a 30-day option to purchase up to 1,393,229 additional
shares of common stock from Phreesia at the public offering price,
less underwriting discounts and commissions.
The offering is expected to close on July
22, 2019, subject to customary closing conditions.
J.P. Morgan, Wells Fargo Securities and William Blair are acting as joint book-running
managers for the offering as representatives of the underwriters.
Allen & Company LLC and Piper
Jaffray are acting as passive book-running managers for the
offering.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
July 17, 2019. Copies of the
registration statement can be accessed by visiting the Securities
and Exchange Commission website at www.sec.gov.
This offering is being made only by means of a prospectus. A
preliminary prospectus describing the terms of the offering has
been filed with the Securities and Exchange Commission and forms a
part of the effective registration statement. A copy of the final
prospectus relating to the offering will be filed with the
Securities and Exchange Commission, and may be obtained, when
available, from J.P. Morgan Securities LLC, c/o Broadridge
Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866-803-9204;
from Wells Fargo Securities, LLC, Attention: Equity Syndicate
Department, 375 Park Avenue, New York,
NY 10152, telephone: 1-800-326-5897; or from William Blair & Company, L.L.C., Attention:
Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone:
1-800-621-0687.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or
jurisdiction.
ABOUT PHREESIA
Phreesia gives healthcare organizations a suite of robust
applications to manage the patient intake process. Our innovative
SaaS platform engages patients in their care and provides a modern,
consistent experience, while enabling healthcare organizations to
optimize their staffing, boost profitability and enhance clinical
care.
Investor Contact:
Balaji Gandhi
Phreesia, Inc.
investors@phreesia.com
(929) 506-4950
Media Contact:
Maureen McKinney
Phreesia, Inc.
mmckinney@phreesia.com
(773) 330-8908
View original content to download
multimedia:http://www.prnewswire.com/news-releases/phreesia-announces-pricing-of-initial-public-offering-300887160.html
SOURCE Phreesia